Statistics
Total Visits
| Views | |
|---|---|
| Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients | 175 |
Total Visits Per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients | 4 | 3 | 0 | 2 | 3 | 2 | 3 | 3 | 4 | 9 | 0 |
File Visits
| Views | |
|---|---|
| CastroIglesias_Angeles_2020_Effectiveness_safety_sofosbuvir_velpatasvir_ribavirin.pdf | 117 |
Top country views
| Views | |
|---|---|
| United States | 123 |
| Sweden | 18 |
| Spain | 7 |
| Germany | 6 |
| Ireland | 4 |
| Ukraine | 3 |
| Australia | 1 |
| Canada | 1 |
| France | 1 |
| India | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 43 |
| Louisville | 19 |
| Fairfield | 17 |
| Mountain View | 6 |
| San Diego | 5 |
| Cambridge | 4 |
| Dublin | 4 |
| San Mateo | 4 |
| A Coruña | 3 |
| Boydton | 3 |
